FDA inspection
G21 USA, Inc.: FDA inspection ending Jul 25, 2023
FDA inspection 1210733 · Voluntary Action Indicated (VAI) · New York, NY
Key facts
| Inspection ID | 1210733 |
|---|---|
| Firm | G21 USA, Inc. |
| FEI number | 3012265577 |
| Address | 120 E 73rd St Apt 3b |
| City | New York |
| State | NY |
| ZIP | 10021 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Jul 25, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Postmarket Assurance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data